A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG‐ACRIN Cancer Research Group (EAQ152)

Enthusiasm for precision oncology may obscure the psychosocial and ethical considerations associated with the implementation of tumor genetic sequencing.

[1]  David M. Thomas,et al.  Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular Profiling , 2020, Translational oncology.

[2]  David J. Sims,et al.  The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design , 2020, Journal of the National Cancer Institute.

[3]  M. Waligóra,et al.  Umbrella and basket trials in oncology: ethical challenges , 2019, BMC Medical Ethics.

[4]  P. Butow,et al.  Patient perspectives on molecular tumor profiling: “Why wouldn’t you?” , 2019, BMC Cancer.

[5]  A. Chinnaiyan,et al.  Next‐generation sequencing in precision oncology: Patient understanding and expectations , 2019, Cancer medicine.

[6]  P. Cuijpers,et al.  Screening and Stepped Care Targeting Psychological Distress in Patients With Metastatic Colorectal Cancer: The TES Cluster Randomized Trial. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[7]  L. Harris,et al.  National Cancer Institute Basket/Umbrella Clinical Trials: MATCH, LungMAP, and Beyond , 2019 .

[8]  A. Shuman,et al.  Revisiting Expectations in an Era of Precision Oncology. , 2018, The oncologist.

[9]  R. Gray,et al.  Abstract B080: Update on the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH/EAY131) precision medicine trial , 2018 .

[10]  D. Cella,et al.  Clinical validity of PROMIS Depression, Anxiety, and Anger across diverse clinical samples. , 2016, Journal of clinical epidemiology.

[11]  K. Nathanson,et al.  Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing , 2015, Genetics in Medicine.

[12]  W. Chung,et al.  Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility , 2014, Genetics in Medicine.

[13]  M. Robson,et al.  American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility. , 2010, Journal of Clinical Oncology.

[14]  A. StAteMent.  ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing , 2014, Genetics in Medicine.

[15]  K. Offit,et al.  Cancer genomics and inherited risk. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Fiona A Miller,et al.  Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care , 2013, European Journal of Human Genetics.

[17]  Laura E. MacConaill,et al.  Existing and emerging technologies for tumor genomic profiling. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  P. Hinds,et al.  PROMIS pediatric measures in pediatric oncology: Valid and clinically feasible indicators of patient‐reported outcomes , 2013, Pediatric blood & cancer.

[19]  L. Garraway,et al.  Attitudes of patients with cancer about personalized medicine and somatic genetic testing. , 2012, Journal of oncology practice.

[20]  C. McBride,et al.  Patients’ understanding of and responses to multiplex genetic susceptibility test results , 2012, Genetics in Medicine.

[21]  Daniel J Buysse,et al.  The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. , 2010, Journal of clinical epidemiology.

[22]  J. Hamilton,et al.  Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. , 2009, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[23]  S. Shiloh.  Illness Representations, Self-Regulation, and Genetic Counseling: A Theoretical Review , 2006, Journal of Genetic Counseling.

[24]  L. Carlson,et al.  Emotional distress: the sixth vital sign in cancer care. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  E. Boyko,et al.  Brief questions to identify patients with inadequate health literacy. , 2004, Family medicine.

[26]  B. Peshkin,et al.  Patient Satisfaction with Cancer Genetic Counseling: A Psychometric Analysis of the Genetic Counseling Satisfaction Scale , 2004, Journal of Genetic Counseling.

[27]  L. Carlson,et al.  High levels of untreated distress and fatigue in cancer patients , 2004, British Journal of Cancer.

[28]  D. Cella,et al.  A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. , 2002, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[29]  M. Horowitz,et al.  Impact of Event Scale: psychometric properties. , 2002, The British journal of psychiatry : the journal of mental science.

[30]  I. Hickie,et al.  Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer , 2001, Psycho-oncology.

[31]  Steven Piantadosi,et al.  The prevalence of psychological distress by cancer site , 2001, Psycho-oncology.

[32]  Keith J. Petrie,et al.  Perceptions of Health and Illness: Current Research and Applications. Edited by K. J. Petrie and J. A. Weinman. Harwood Academic Publishers: New York. 1998. , 1999, Psychological Medicine.

[33]  Yael Benyamini,et al.  Illness representations: Theoretical foundations. , 1997 .